Immunomodulatory Properties of BCG: Implications for MTCT

Post Date: 
2008-06-01
Summary: 

To evaluate the immune activating properties of BCG vaccination in neonatal CD4 cells and test the hypothesis that neonatal BCG vaccination leads to activation of immune response that may increase the susceptibility to HIV infection in breast-fed infants of HIV-positive mothers.